Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Author:
Funder
ADC Therapeutics SA
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference45 articles.
1. Current therapeutic results and treatment options for older patients with relapsed acute myeloid leukemia;Ferrara;Cancers (Basel),2019
2. Emerging treatments in acute myeloid leukemia: current standards and unmet challenges;Percival;Clin. Adv. Hematol. Oncol.,2017
3. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gokbuget;Blood,2012
4. Current approaches in the treatment of relapsed and refractory acute myeloid leukemia;Ramos;J. Clin. Med.,2015
5. Incidence and survival of hematological cancers among adults ages >/=75 years;Krok-Schoen;Cancer Med.,2018
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting CD25+ lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents;British Journal of Haematology;2024-07-30
2. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?;Cells;2024-06-01
3. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01
4. A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression;Clinical Cancer Research;2023-11-15
5. What’s new in the use of antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers for cancer therapy?;Expert Opinion on Biological Therapy;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3